chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case received via the regulatory authority (reference number: 21-128824) on Aug 10, 2021, and forwarded to Moderna, reported by a consumer, describes the occurrence of product administered to patient of inappropriate age (16 years old when he received the first dose of the Moderna vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced product administered to patient of inappropriate age (16 years old when he received the first dose of the Moderna vaccine). At the time of the report, product administered to patient of inappropriate age (16 years old when he received the first dose of the Moderna vaccine): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Ever since receiving the shot, the patient's arm where the pneumonia vaccine was administered, has been sore. Last night, she noticed that her arm around the injection site was splotchy and red. There are visible red bumps. It is very sore to the touch. She also noticed redness on the bottom of her right foot. No treatment has been started. Per nurse, at her doctor's office, she is to use oral BENADRYL and apply ice to the area.
Patient was seen at ER yesterday evening for evaluation of facial rash that developed approximately 8 hours after receiving flu mist vaccine.  She denies fever, chills, lip or throat swelling, or pruritis and the rash is confined to her face primarily the cheeks.  Patient has not previously received any flu vaccine.  She was given Benadryl at hospital and told to follow up in clinic.  No signs or symptoms of anaphylaxis.
19 month old. Shots couple of days ago, now with hives on neck and face. Widespread hives this AM. Mon noting, hives today coming and going legs/abdomen now on face, no dyspnea. On Wednesday this week had Hep A/PCV and DTAP injections. Afebrile, mild rhinorrhea and one loose stool today as well. Sleeping now, not noting itching. No new foods introduced.
Vaccine Administered: Pfizer COVID-19 Patient reaction:  Flushing Pale Skin Nausea/Vomiting Fainting Dizziness Action taken: Antihistamine given. Outcome: Patient recovered.    Late charting for 5/17/2021 - 5ml Diphenhydramine given PO 10 minute after c19 vaccine - patient dizzy, diaphoretic, and nauseous.     Emergency medication entered and signed.
claimant alleges that on 5JUN87, pt recvd 2nd DTP/OPV immun resulting in paralysis/weakness in both arms & hands; hospitalized 21SEP97; dx poliomyelitis;
The pt experienced a rash on 9/8/00. The rash started late on 9/7/00. The rash was characterized and an erythematous papular rash with coalescence. Blanches on the face, chest, abdomen, back, arms and legs. None were on the feet or hands.
An 18 year old patient received the 1 mL (adult dose) in error.; An 18 year old patient received the 1 mL (adult dose) in error; This case was reported by a nurse via sales rep and described the occurrence of accidental overdose in a 18-year-old female patient who received HBV (Engerix B) for prophylaxis.   On 11th May 2022, the patient received the 1st dose of Engerix B 1 ml. On 11th May 2022, unknown after receiving Engerix B, the patient experienced accidental overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the accidental overdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 19-MAY-2022 Reporter's Comment: An 18 year old patient received the 1 mL (adult dose) in error.  The nurse thought that because the patient was 18 years old, the adult dose was due and recommended.  The patient did not experience any adverse events per the reporter.  Office called to get guidance for doses 2 and 3 (volume). The reporter did not consent to follow-up. Additional supportive information: 18 year old patient received 1 mL (adult dose) of Engerix B in error, which led to Inappropriate age at vaccine administration and Accidental overdose.
Information has been received from a registered nurse concerning a two year-old patient, on an unknown date, was vaccinated with a dose of (Merck) PROQUAD (dose and route not provided, lot # j00040, expiry date 04-JUL-2014) and a dose of (Merck) VARIVAX (dose and route unknown, lot # reported as h020248, expiry date 08-NOV-2014) at the same visit. No adverse effects were reported. Additional information has been requested.
Information has been received from a licensed practical nurse (LPN) concerning a patient who on 08-JAN-2009 was vaccinated with PNEUMOVAX (lot number 662663/0980X). The patient developed severe cellulitis reactions immediately after or by the evening of PNEUMOVAX administration. The patient had symptoms, which included swelling, redness, pain and heat at the injection site. The patient sought medical attention at an emergency room. The patient was treated for cellulitis and was put either on an (unspecified) antibiotic and/or (unspecified) steroid. The outcome of the patient's adverse reaction was not reported. This is one of several reports received from the same source. Additional information has been received from the office manager who confirmed that several patients had injection site reactions. Additional information has been received from a licensed practical nurse (LPN) concerning a 68 year old male patient who on 12-JAN-2009 9:30 AM was vaccinated IM with the first dose of PNEUMOVAX vaccine (Lot number 662663/0980X). Subsequently, the patient developed weakness and pain in arm, redness, heat at site, edema, and fever. Subsequently, the patient was recovered from the adverse events in 5-7 days. It was not reported whether the patient sought medical attention. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
Fever of 103.7, vomiting, diarrhea, myalgia, shaking chills, called 911
Developed Cystitis in arm due to no lymph nodes under arm.  Did not realize I could get vaccine in thigh..  So far I have received 3 Infusions of Rocephin.  I am also on day 3 of oral Bactrim.  The redness and swelling seems to be getting better.  I am to continue the Bactrim for 7 days.  I will contact the Doctor Monday to see if I need another Rocephin infusion.
Pt recvd 2 doses of Engerix-B & 2 wks p/each inject exp joint pain, fatigue, weakness & hair loss which persist;
This case was reported by a pharmacist  via sales rep and described the occurrence of injection site itching in a adult patient who received FLUARIX quadrivalent. In 2015, the patient received FLUARIX quadrivalent 1 ml. On an unknown date, an unknown time after receiving FLUARIX quadrivalent, the patient experienced injection site itching. On an unknown date, the outcome of the injection site itching was unknown. It was unknown if the reporter considered the injection site itching to be related to FLUARIX quadrivalent. Additional details were received as follows: The reporter stated that, they vaccinated to their hospital employees. Out of them 3 patients were experienced adverse events. In 2015, the patient experienced itching at the injection site that went down the arm. The reporter did not have any further information. This case was linked with case US2015152966 and US2015152964, reported by the same reporter.
2 days after the vaccination I developed a rash in the lower back and on the left and right shoulder and was really itchy.  It came and went for a couple hours and the next day it got worse which made me reach out and have a virtual visit and was advised to take benedry which did help.  The rash appeared as a hive.
Starting 05/22/2022. I developed fatigue, nasal congestion, productive cough and hoarseness. Then, on 05/23/2022, I was losing my voice so I did the at home test and that was positive. That same day, I went to my job and got the PCR test done and it came back on 05/24/2022 as positive. I contacted my PCP on 05/23/2022 when I tested positive and on 05/25/2022 he called me to let me know that he ordered PAXLOVID and my daughter picked it up for me and I started it that same day. I took the PAXLOVID for 5 days and then I ended that on Sunday. On 06/04/2022, I woke up with a sore throat, nasal congestion and fatigue. I did a home rapid test and it was positive. I am waiting it out at this point.
Swelled upr arm turned red past elbow, fever, pain. ER doc treated with antibiotics.
Patient report red bump that is heated to the touch starting the same night of the vaccination. Since then, it has grown in size.
Sluggish; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (Sluggish) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced SLUGGISHNESS (Sluggish). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, SLUGGISHNESS (Sluggish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
My throat got sore and was sore for a couple weeks. I went to an urgent care and  was tested for a flu and COVID-19 Test were negative. I was also negative for strep. I was prescribed antibiotics and completed the treatment but my throat was still sore. I went back to the urgent care and was given another round of antibiotics. I decided to see an ENT at Hospital. They did a scope down my throat and advised me that I had cancer in the Epiglottis. I had a biopsy done which confirmed cancer. I went to get 7 weeks of radiation daily. I had a total of 35 treatment. So far there are no signs of the disease. I am scheduled for a scan and another scope in October. I do not believe I have completed recovered as I am still having side effects like swelling and edema in the throat area. I still have fatigue and trouble moving my head. Some days its hard to swallow but my voice is good some days and some days its not.
Approximately 20 hours after vaccine provision I began to get sore muscles, fever/chills (which lasted about 24 hours total), which was expected. By 24 hours it had become extremely painful, one of the worst "sick ex, and accompanied with extreme vomiting and dry heaving. The next 8 hours were spent on my bathroom floor, unable to keep even small sips of water down, with continued retching despite having emptied my stomachs content hours previous.
my arm was just red for two weeks; This spontaneous case was reported by a physician assistant and describes the occurrence of ERYTHEMA (my arm was just red for two weeks) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included METOPROLOL for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced ERYTHEMA (my arm was just red for two weeks). On 20-Jan-2021, ERYTHEMA (my arm was just red for two weeks) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not reported. It was reported that the arm was red for two weeks.   This case was linked to MOD-2021-017387 (Patient Link).
Dose of Shingrix which had been reconstituted with sterile water; Accidentally given a dose of Shingrix which had been reconstituted with sterile water; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 2YS59, expiry date 08-FEB-2024) for prophylaxis.   On 12-MAY-2023, the patient received Shingrix. On 12-MAY-2023, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Dose of Shingrix which had been reconstituted with sterile water) and inappropriate dose of vaccine administered (Verbatim: Accidentally given a dose of Shingrix which had been reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date:12-MAY-2023 HCP called in to report that a patient was accidentally given a dose of Shingrix which had been reconstituted with sterile water. They asked for medical information, accepting it be sent and gave information about patient, vaccine and vaccination. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented for follow up. The patient accidentally received a dose of Shingrix which had been reconstituted with sterile water, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Postpartum Preeclampsia: Hospitalization from 11/9/2021-11/11/2021 and again 11/12/2021-11/14/2021.   Signs/Symptoms: severe headache, stiff neck, blurred vision, flashes of light, blacking out, nausea, disorientation  My son was born on 11/2021. On 11/8/2021 I started feeling unwell.  I had a wellness check on 11/9/2021 and they discovered my blood pressure was in hypertension crisis. 186/103. I was placed on magnesium drip for 24 hours and was put on Hydralazine.  I was discharged on 11/11/2021. The next day on 11/12/2021 I started feeling unwell again. I took my blood pressure and it was 203/110. I was readmitted to the hospital and placed on magnesium drip for 24 hours again and then they increased my medications: hydralazine 4x a day, Nifedipine XL 2x a day, and Atenolol 1x a day, and modified bed rest for 12 weeks. They are unsure what caused these events, as I did not have high blood pressure during my pregnancy.
(R) deltoid muscle area red and swollen (entire area surrouding injection area). Shoulder very sore. Patient has trouble lifting (R) arm.
Systemic: Chest Tightness / Heaviness / Pain-Moderate, Systemic: pain in leg-Moderate, Additional Details: Patient started experiencing side effects the same night she received the shot. Patient has been treated with steroids, gabapentin, statin, co-q10, and Xanax. Chest pain subsided after 3 weeks. Other symptoms still remain. Sonogram of legs came back negative for blood clot.
Information has been received on 18-JUL-2018 regarding a case in litigation from a lawyer and the spouse of a deceased male consumer. The patient's prior concurrent conditions, medical history and concomitant medications are unknown. On or about 27-JAN-2012, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a county health district as recommended for routine adult health maintenance for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 19-JAN-2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed FAMVIR, acetaminophen, NORCO and NEURONTIN for management of his painful symptoms and excruciating pain. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses and pain and suffering and other damages. On 24-FEB-2017, the patient passed away. The cause of death was not reported. Upon internal review, passed away was considered to be medically significant. Additional information has been requested. Reported Cause(s) of Death: passed away.
Pt developed generalised achiness with joint pains and c/o "not feeling well". Also had local reaction with erythema & tenderness at site of inj. S/S subsided after a few days (5-7).
So on about May 26th or 27th, I started to have a head cold. On Sunday, June 5th, 2022 I tested positive for COVID-19 on an at home test and it came back positive.
Administered MMR Vaccine 06/15/06.  06/25/06 reported "rash" raised and irregular, beginning on arms, spreading to chest, trunk of body and legs.  Rash itched.  Reported joint pain throughoutbody that began 06/27/06.  Reported lymph glands in neck slightly swollen also.  06/28/06 reported symptoms were improving.  Treated rash, because of itching with oral antihistamine and obtained relief.  Treated aching with oral ibuprofen.  06/29/06 reported she continued to have joint pain throughout body to point that she had difficulty raising her arms up and lifing her feetas well as some limited sensation in some of her fingers on one of her hands.  Sought medical attention 06/29/06. Completed blood testing for rheumatoid arthritis and did a sed rate.  Results were both at the "high end of normal".  Was taken off two medications to determine if these possibly were causing a reaction.  (Lipitor and Bactrim DS)  MD requested she restart medications one month apart after resolution of symptoms.  Patient reports she did restart medications without difficulty.
blood sugars stayed below 200 for two weeks then went back up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (blood sugars stayed below 200 for two weeks then went back up) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01IJ20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, ERTUGLIFLOZIN PIDOLATE (STEGLATRO), INSULIN GLARGINE, LIXISENATIDE (SOLIQUA), INSULIN GLARGINE (LANTUS), FENOFIBRATE, LISINOPRIL and ATORVASTATIN for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced BLOOD GLUCOSE DECREASED (blood sugars stayed below 200 for two weeks then went back up). On 20-Jan-2021, BLOOD GLUCOSE DECREASED (blood sugars stayed below 200 for two weeks then went back up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs are not provided by reporter.   This case was linked to MOD-2021-016534 (Patient Link).
Erythema Multiforme started at ankles, moved up legs, and then started forming on arms. Used Clobetasol Propionate when spots started getting large (larger than half inch) and blisters started forming. After 3 months, Erythema Multiforme cleared up, but left hyperpigmentation all over arms and legs and thighs. Erythema evolved to Chronic Spontaneous Urticaria. Urticaria appears randomly without cause around belly button area, back, arms, and in same spots where the Erythema was present. Prescribed Triamcinolone and it does help but quickly relapses within 2-3 weeks. Antihistamines have not helped.
Patient had reaction that looked like red ring around the injections site which was developed 2 days after getting her flu vaccine
Initial c/o heaviness in legs and arms, by next day malaise lasting 2.5 weeks after vaccine.  Still "does not feel like herself".  Continues to have heaviness and has not been able to resume daily activities.  She has also noted intermittent diarrhea and has frequent periods where her face and especially her forhead feel very warm it lasts several minutes and then goes away.  She does not looked flushed at these times.  No fever reported.
pt recv vax & had a violent rxn of n,v, diarrhea, etc that lasted approx 1wk;
Initial report received from the patient's parent on 21 June 2011. An 11-year-old female patient had received a first dose of ADACEL (lot number C3540AA), and a first dose of MENACTRA (lot number U3518AA) on 18 January 2011 and 1 week post vaccinations the patient experienced the "usual" redness and soreness, but every so often for the "past 6 months" she has developed a welt below the right injection site lasting 3-4 hours, and then it goes away. The patient was evaluated by an allergist and dermatologist, but they were unable to determine the cause. It was noted the patient had received VARIVAX (Merck) in June 2010. No adverse event was reported with that vaccination. Documents held by sender: None.
pain at the injection site, fatigue, headache, myalgia, arthralgia swelling at the injection site. Taking Tylenol for the pain, seems to be working. Sleeping for the fatigue.
elevated temp starting on 7SEP95;rash around neck on 10SEP95 & 11SEP95 rash on torso & head;no inc temp since rash onset
Raised area of induration and redness, urticaria at site of vaccine administration noted next morning with pain.
Tendon and bicep area aching and pain. Inner elbow, as well-pain. Slow to heal from normal activity since vaccination, on side of vaccination which is my right arm-right arm received both shots.
Pt received Hib, polio, and Prevnar on 2/20/01. Prevnar was given one time before, HIB and polio had 2 previous doses. Pt returned 2/21 with hives, red, sore, and itchy.
In 1986 the patient was vaccinated with 1 dose of varicella virus vaccine live. It was reported that "over 2 weeks there was a gradual onset beginning of an eczematous rash with a few blisters that broke easily and dried quickly. The patient was seen by a physician and treated with acyclovir after 10 days and resolved fairly rapidly over the week. The patient also developed a blister on her other cheek. Additionally, a burning feeling and occasional itching were noted. The patient's brother experienced a reaction following exposure to varicella vaccine live. No further information is available.
swelling at the injection site after second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site after second vaccine) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site after second vaccine). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site after second vaccine) outcome was unknown.            Concomitant medications were not reported. treatment medications were not reported.